Analyst Ratings for Mural Oncology (MURA)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/25/2025 | Morgan Stanley | Judah Frommer | Downgrade | Equalweight (Overweight) |
N/A (N/A) |
3.83 (2.04) |
-46.74% | Details |
| 3/25/2025 | Raymond James » Updated 4/15/2025 |
Laura Prendergast | Downgrade | Outperform (Strong Buy) |
4.00 (6.00) |
3.83 (2.04) |
-46.74% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


